CASK is the mammalian ortholog of LIN2, a component of the LIN2/7/10 protein complex that targets epidermal growth factor receptor (EGFR) to basolateral membranes in C. elegans. A member of the MAGUK family of scaffolding proteins, CASK resides at basolateral membranes in polarized epithelia. Its interaction with LIN7 is evolutionarily conserved. In addition, CASK forms a complex with another MAGUK, the DLG1 tumor suppressor. Although complete knockout of CASK is lethal, the gene is X-linked, enabling us to generate heterozygous female adults that are mosaic for its expression. We also generated intestine-specific CASK knockout mice. Immunofluorescence analysis revealed that in intestine, CASK is not required for epithelial polarity or differentiation but is necessary for the basolateral localization of DLG1 and LIN7C. 3
Introduction
Membrane-associated guanylate kinases (MAGUKs) are cytoplasmic scaffolding proteins that organize macromolecular complexes at specialized regions of the plasma membrane (Funke et al., 2005) . In recent years, it has been increasingly recognized that MAGUKs play critical roles in the establishment of intercellular junctions and the maintenance of cell polarity (Caruana, 2002) . CASK is the mammalian ortholog of LIN2, a C. elegans MAGUK that was first identified as one of a group of three interacting proteins (LIN2, LIN7 and LIN10) required for basolateral localization of the epidermal growth factor receptor (EGFR) in certain polarized epithelial cells . In the absence of the LIN2/7/10 protein complex, the C. elegans EGFR is mislocalized to the apical membrane, implying that this tripartite complex functions in basolateral protein targeting.
All three members of the LIN2/7/10 complex are evolutionarily conserved, and they are expressed by and associate within mammalian neurons (Borg et al., 1998; Butz et al., 1998) .
Although mammalian epithelial cells do not express the ortholog of LIN10, they do express both CASK and LIN7. (There are three closely related LIN7 isoforms in mammals, designated LIN7A,B,C/Velis-1,2,3/MALS-1,2,3; the one most widely expressed outside the nervous system is LIN7C (Butz et al., 1998; Irie et al., 1999; Jo et al., 1999) .) The shared domain that mediates the CASK-LIN7 interaction is highly conserved (Doerks et al., 2000) , and these two proteins can be co-immunoprecipitated from the Madin-Darby Canine Kidney (MDCK) epithelial cell line Stetak et al., 2006) . Evidence from multiple studies suggests that LIN7 functions in the basolateral targeting of membrane proteins in mammalian epithelial cells (Perego et al., 1999; Straight et al., 2001; Alewine et al., 2007) . Furthermore, LIN7 appears to play a special role in regulating the mammalian EGFR family members (the ErbB receptors) by promoting both their trafficking through the biosynthetic pathway and their stability at the basolateral plasma membrane (Shelly et al., 2003) .
We showed previously that in human intestinal epithelial cells, CASK is basolaterally localized (Cohen et al., 1998) and complexed with another MAGUK, discs-large homolog 1 (DLG1) (Nix et al., 2000) . Null mutations of the discs-large (Dlg) gene in Drosophila lead to loss of polarity, disorganization and marked overgrowth of imaginal disc epithelial cells during development (Stewart et al., 1972) . Genetic studies have defined two other such "neoplastic tumor suppressor" genes with similar mutant phenotypes; these genes act in concert with Dlg to regulate embryonic epithelial polarity and proliferation (reviewed in (Bilder, 2004) ). There is much evidence that mammalian DLG1 is also a tumor suppressor: it binds to the adenomatous polyposis coli (APC) protein to form a complex that regulates cell cycle progression (Ishidate et al., 2000) , it is a critical target of several viral oncoproteins (Lee et al., 1997; Grassmann et al., 2005; Thomas et al., 2005) , its decreased expression in human cervical dysplastic lesions correlates with malignant progression (Watson et al., 2002; Cavatorta et al., 2004) , and it is often genetically altered in breast cancer (Fuja et al., 2004) .
A murine CASK mutant generated by insertional mutagenesis (Laverty and Wilson, 1998) and CASK knockout mice produced via Cre-Lox technology (Atasoy et al., 2007) both exhibit cleft palate and die within twenty-four hours after birth. In order to study the function(s) of CASK in adult epithelia in vivo, we took advantage of the fact that the CASK gene is located on the X chromosome and is therefore transcriptionally silenced by X-inactivation during embryogenesis in females. We show here that female mice heterozygous for the null allele of CASK are viable and healthy but are mosaic for CASK expression in all tissues examined.
CASK-deficient epithelial cells are histologically indistinguishable from their CASK-expressing neighbors but show tissue-specific defects in the subcellular localization of LIN7C and DLG1. Surprisingly, the absence of CASK has no effect on the basolateral localization of either EGFR or ErbB-2 in the intestinal epithelium.
Materials and Methods
Mice. CASKflox mice were the generous gift of Dr. Thomas Südhof (Stanford University). PrmCre (129-Tg(Prm-cre)58Og/J, stock #003328) and Vil-Cre (B6.SJL-Tg(Vil-cre)997Gum/J, stock #004586) mouse strains were obtained from the Jackson Laboratory (Bar Harbor, Maine).
Genotyping was performed by PCR amplification of CASK and Cre sequences from genomic DNA of tail samples, as described (Saam and Gordon, 1999; Atasoy et al., 2007) . Murine epidermal growth factor (EGF; #354001) was obtained from BD Biosciences (Bedford, MA) and was reconstituted in sterile phosphate-buffered saline (PBS) at 100 g/ml immediately before use. For EGF experiments, each mouse received 25g of the growth factor or an equal volume of PBS by retro-orbital intravenous injection and was sacrificed 5 to 20 minutes later. For cell proliferation and migration studies, 1-1.25 mg bromodeoxyuridine (#550891, BD Pharmingen) per mouse was injected intraperitoneally, and animals were sacrificed at 1 or 24 hours thereafter.
All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee at Yale University.
Antibodies. Rabbit polyclonal anti-CASK antibodies used in this study were those generated previously (Cohen et al., 1998) as well as those from Zymed/Invitrogen (#71-5000). Monoclonal anti-CASK antibodies were from Chemicon/Millipore (#MAB5230). Anti-DLG1 (#610874),
anti-E-cadherin (#610181), anti--catenin (#610153), anti-BrdU (#555627) and anti-syndecan-1 (#553712) were from BD Biosciences Pharmingen; anti-LIN7 (recognizing all three isoforms; #184 003) was from Synaptic Systems; anti-LIN7C/Velis-3 (#51-5600), anti-ZO-1 (#33-9100), anti-occludin (#71-1500) and anti-claudin-5 (#34-1600) were from Zymed/Invitrogen; goat antiscribble (#sc-11048), mouse anti-PKC (#sc-17781) and rabbit anti-integrin 1 (#sc-8978) were from Santa Cruz Biotechnology, Inc.; rabbit anti-human chromogranin A and anti-human lysozyme were from Dako; anti-villin-1 (#2369), anti-phospho-EGFR (Tyr1173; #4407) and anti-ErbB-2 (#2242) were from Cell Signaling Technology, Inc.; monoclonal anti-actin was from Sigma (#A4700); the anti-EGFR used for immunoblotting was from Upstate/Millipore (#06-847). The anti-Na + ,K + -ATPase used was mouse monoclonal antibody "5" (Takeyasu et al., 1988) , and rabbit anti-II-spectrin was the affinity-purified "RAF-A" antibody (Harris et al., 1986) . Secondary antibodies used in Western blots were horseradish peroxidase conjugates (Sigma and Chemicon). Secondary antibodies used for immunofluorescence were Alexa fluor 488 and 568 conjugates (Molecular Probes/Invitrogen).
Immunofluorescence. Tissues were fixed in 4% paraformaldehyde or periodate-lysineparaformaldehyde (McLean and Nakane, 1974) overnight at 4C before embedding in paraffin.
Antigen retrieval was performed using a pressure-cooker containing citrate or EDTA buffer.
Slides were pre-incubated with blocking buffer (5% goat serum, 1% bovine serum albumin in Tris-buffered saline (TBS)) for 1-2 hours at room temperature. Primary antibodies were diluted in blocking buffer and incubated with sections overnight in a humidified chamber at 4C. Slides were then washed five times in TBS, once in TBS/0.01% Triton X-100, and once again in TBS (3 minutes per wash). Secondary antibodies were diluted in blocking buffer and incubated with sections for one hour at room temperature in the dark. After washing in TBS as before, slides were coverslipped with a 4,6-diamidino-2-phenylindole (DAPI)-containing, antifade mounting medium (ProLong Gold, Molecular Probes/Invitrogen). Sections were viewed on Zeiss Axioskop and Olympus IX70 fluorescence microscopes, and photomicrographs were obtained using CytoVision (Applied Imaging/Genetix) and Spot (Diagnostic Instruments, Inc.) digital imaging systems.
Intestinal mucosal preparation. Wild type and Vil-Cre-CASK KO animals were sacrificed, and colons were immediately removed, placed on an ice-cold surface and opened longitudinally with dissecting scissors. Feces were discarded, and the mucosa was collected by scraping with a glass slide. Mucosal samples were homogenized in ten volumes of 2X protein sample buffer, using a glass homogenizer with a motor-driven Teflon pestle.
Results

Generation of CASK mosaic mice
Because the CASK gene is X-linked, females heterozygous for a null allele are predicted to be mosaic for CASK expression. We obtained transgenic mice bearing a CASK allele (CASKflox) in which the first coding exon is flanked by loxP recombination sites (Atasoy et al., 2007) . These mice were mated with a transgenic strain (Prm-Cre) in which Cre recombinase is expressed exclusively in the male germline. Male progeny bearing both the CASKflox and Prm-Cre alleles were then crossed with wild type females to produce CASK +/-female progeny. These CASK heterozygotes are viable, healthy and phenotypically indistinguishable from wild type females.
Genotypes were confirmed by PCR amplification from genomic DNA of the wild type and recombined (knockout) alleles of CASK. No morphologic abnormalities were found at necropsy, and microscopic surveys of all tissues revealed normal histology.
In order to demonstrate the mosaicism of CASK expression in CASK +/-mice, we examined multiple tissues by immunofluorescence microscopy. Female CASK heterozygotes show patchy CASK expression in epithelia of the stomach ( Figure 1A ), small and large intestine (Figure 1B and C) , pancreas and kidney, in mosaic patterns consistent with X-inactivation (Griffiths et al., 1988; Novelli et al., 2003) . The tight junction localization of ZO-1 appears intact in all of these tissues, both within CASK-expressing and CASK-deficient epithelial cells.
CASK deficiency does not alter intestinal epithelial cell polarity or differentiation
Since CASK is thought to function in the organization and maintenance of the basolateral membrane in polarized epithelial cells, we next sought to determine whether CASK deficiency is associated with an altered distribution of basolateral marker proteins. The adherens junction components, -catenin ( Figure 1D ) and E-cadherin (not shown) appear localized along the lateral plasma membranes of intestinal epithelial cells, whether or not CASK is present. Similarly, basolateral expression of the extracellular matrix receptor, integrin 1 ( Figure 2E ), the Na Figure S1A ) and the heparan sulfate proteoglycan, syndecan-1 ( Figure S1B ) are intact in CASK-deficient intestinal epithelial cells. The cytoskeletal protein, II-spectrin localizes to the cortical actin network at the basolateral membrane and to the terminal web underlying the apical brush border in small intestinal epithelia; this distribution is unaltered in CASK-deficient cells ( Figure 2F ).
In addition to the tight junction-associated MAGUK, ZO-1, the integral membrane tight junction components, occludin and claudin-5 were examined in CASK mosaic intestine and were found to show the same subcellular distribution in normal and CASK-deficient epithelial cells ( 
Basolateral polarity proteins are mislocalized in CASK-deficient intestinal epithelium
Immunofluorescence double-labeling of CASK mosaic small and large intestine revealed that while wild type epithelial cells show coincident basolateral membrane staining for CASK and DLG1, CASK-deficient cells have no detectable basolaterally-localized DLG1 ( Figure 3A -F). To rule out an immunofluorescence artifact (e.g., "bleedthrough" of one color into another wavelength emission channel), we did single-labeling experiments and found that patches of epithelium lacking basolateral DLG1 were easily identifiable, even when no anti-CASK antibody had been applied to the tissue ( Figure S1C ). Moreover Scribble (Scrib), the mammalian ortholog of a Drosophila neoplastic tumor suppressor and a member of the highly conserved group of proteins (the Lgl/Dlg/Scrib polarity complex) that control membrane polarity, also appears absent from the basolateral membrane in CASK-deficient intestinal epithelia ( Figure 3G-I) .
The CASK-LIN7 interaction, originally identified in C. elegans, is conserved in mammalian neurons (Butz et al., 1998) and in renal epithelium . We We next wanted to determine whether the disappearance of selected proteins from the basolateral membranes of CASK-deficient cells is associated with loss of those proteins or whether they are still present but in a diffuse intracellular distribution that is difficult to detect above background fluorescence levels. Because only a small percentage of the total intestinal epithelium is CASK-deficient in our mosaic animals, they are not suitable for quantitative analysis. We therefore generated intestine-specific CASK knockout mice in which the entire intestinal epithelium is genetically null for CASK. This was accomplished by crossing CASKflox mice with a transgenic strain that carries the Cre recombinase gene under the control of a villin promoter (Vil-Cre) (Madison et al., 2002) . Male progeny that inherit both the CASKflox allele and the Vil-Cre transgene are viable and healthy but show a complete absence of CASK throughout the intestine on immunofluorescence analysis ( Figure S2A, B) . PCR performed on genomic DNA isolated from the intestinal mucosa of these mice confirmed the presence of the recombined CASK allele (CASK-ko). No basolateral DLG1 or LIN7C could be identified in the small or large intestinal epithelium by immunofluorescence ( Figure S2 ).
Western blots of colonic mucosa from Vil-Cre CASK knockout mice and wild type littermate controls revealed that although there is no CASK protein in the knockout intestine, DLG1, Scribble and LIN7C are all easily detectable and are present at levels comparable to those in wild type mucosa ( Figure 6 ). Thus, the disappearance of these proteins from the basolateral membranes of CASK-deficient cells by immunofluorescence is not due to their degradation or down-regulated expression, but rather indicates mislocalization.
CASK deficiency does not alter intestinal epithelial homeostasis
The intestinal epithelium of adult mammals undergoes continuous self-renewal in which stem cells at the bottoms of the crypts of Lieberkühn give rise to progenitor cells that proliferate and differentiate as they move up the crypt-surface/villus axis, eventually to be shed into the intestinal lumen (van der Flier and Clevers, 2008) . This homeostatic process takes place in a highly organized spatio-temporal pattern and offers an excellent system in which to study epithelial proliferation and migration.
In females, X chromosome inactivation occurs early in development, before morphogenesis of the crypt-villus architecture, and X-inactivation patches in the adult intestine typically contain multiple adjacent crypt-villus units (Griffiths et al., 1988) 
CASK and LIN7C show normal localization in DLG1-deficient intestinal epithelium
Dlg1
-/-mice, which are genetically null for DLG1, die soon after birth and show multiple craniofacial and urinary tract defects but no apparent gastrointestinal abnormalities (Mahoney et al., 2006) . Immunofluorescence staining of embryonic day 16 intestine from these Dlg1 knockout mice and their wild type siblings revealed that CASK and LIN7C are properly localized in the absence of DLG1 (Figure 8 ). Thus, although CASK is necessary for DLG1 basolateral localization, there is no reciprocal requirement of DLG1 for CASK basolateral localization in intestinal epithelium.
CASK does not influence DLG1 or LIN7C localization in gastric fundic glands
In wild type animals, CASK and DLG1 are expressed in the stomach and show an overlapping basolateral membrane distribution in epithelial cells of the fundic (acid-producing) glands.
Immunofluorescence staining of CASK mosaic stomach, however, revealed that DLG1 maintains its basolateral membrane distribution in this tissue, even in the absence of CASK ( Figure 9A -C).
In wild type animals, the subcellular distribution of LIN7C in gastric glands differs from that in intestinal epithelium. Gastric epithelial cells (which include acid-producing parietal cells, zymogenic chief cells and surface mucous cells) exhibit LIN7C staining at tight junctions but not along basolateral membranes ( Figure 9E ). In parietal cells, there is an intracellular punctate staining pattern suggestive of overlap with the extensive internal tubulovesicular system that characterizes these unusual cells (Ogata, 1997) . In mosaic animals, the localization pattern of LIN7C in CASK-negative gastric epithelium is the same as that in the adjacent, wild type gastric glands ( Figure 9D-F) .
CASK is not required for basolateral expression of EGFR and ErbB-2 in intestinal crypts
In order to test CASK-deficient colonic epithelia for the presence of EGFR on the basolateral cell surface, we injected EGF intravenously into CASK mosaic mice and assayed for EGFR activation by immunofluorescence using an antibody that specifically recognizes phosphorylated EGFR (pEGFR). As shown in Figure 10 , pEGFR is found at epithelial basolateral membranes in the bottom two-thirds of both wild type and CASK-negative crypts. Interestingly, the distribution of pEGFR along the lateral cell membrane differs from that of CASK. Whereas CASK is most highly concentrated at the basal aspect of the lateral membrane, the distribution of pEGFR appears uniform along most of the basolateral membrane, but shows a slight concentration at the apical border, at or near the apical junctional complex. The intensity and localization pattern of pEGFR staining in CASK-deficient crypts is identical to that in wild type crypts. Approximately equal amounts of total EGFR protein are detected in colonic mucosal lysates from wild type and Vil-Cre CASK knockout mice by immunoblot analysis ( Figure S5 ).
Immunolocalization of ErbB-2 in these samples demonstrates that it, too, is basolaterally localized in both wild type and CASK-deficient epithelium ( Figure 10D -F) . The lateral membrane distribution of ErbB-2 is very similar to that of EGFR, with a slight accumulation at tight junctions. Unlike EGFR, however, ErbB-2 appears more evenly distributed along the cryptsurface axis, with only a subtle diminution of staining intensity in the colonic surface epithelium.
We could not detect pEGFR in the epithelium of small intestinal villi, although we found it to be present in both wild type and CASK-deficient small intestinal crypts. The distribution pattern of ErbB-2 in the small intestine parallels that of LIN7A/B; it is most abundant in crypts, weakly expressed at the bases of villi, and undetectable in the fully mature epithelium of the villus tips.
Discussion
Somatic mosaic analysis is a powerful tool for studying tissue morphogenesis; its usefulness in Drosophila research is well established (Blair, 2003) . Although methods for mosaic analysis of mice are less developed, there is increasing interest in using this approach, especially in the study of carcinogenesis (Akyol et al., 2008) . The intestinal epithelium is particularly amenable to mosaic analysis because it undergoes continual, rapid self-renewal while maintaining a precise spatiotemporal organization. Mosaicism driven by X inactivation has been visualized in the murine intestine through histochemical detection of two X-linked enzymes in heterozygous females (Griffiths et al., 1988; Shiojiri and Mori, 2003) . In this previous work, X-linked gene expression was used as a marker to identify clonal patches of epithelium.
Our study has shown that CASK, too, can be used to identify clonal X-inactivation patches. In addition, it has revealed that although CASK-deficient intestinal epithelium is viable, differentiates normally and is able to self-renew, its growth is at a subtle disadvantage compared to wild type epithelium. This is evidenced by the finding that in adult CASK +/-mosaic mice CASK-deficient crypts comprise only about 15% of the total crypt number. In rodents, crypt morphogenesis occurs during the first postnatal week, and with respect to X inactivation, crypts rapidly become homogeneous (Shiojiri and Mori, 2003) . During subsequent growth of the animal and in response to inflammation and/or injury, crypts replicate by a process termed crypt fission (Yen and Wright, 2006) . The fact that CASK-deficient crypts constitute considerably less than half of the epithelium in female mosaics implies either that CASK-deficient cells are less likely than wild type to become established as crypt stem cells during development or that wild type crypts subsequently have a selective advantage over CASK-deficient crypts.
In CASK-negative intestinal epithelia of both mosaic mice and intestine-specific CASK knockout mice, DLG1 and LIN7C fail to adopt their normal basolateral membrane distribution.
This finding of an in vivo requirement for CASK in the basolateral localization of DLG1 and LIN7C is consistent with the results of previous studies conducted on renal epithelial cells in vitro. Overexpression of a mutant, mislocalizing form of CASK in MDCK cells has been shown to partially disrupt the basolateral localization of endogenous DLG1 and LIN7 . However, we find that CASK is not required for DLG1 or LIN7C localization in gastric fundic epithelium. Thus, its roles in epithelial basolateral membrane organization appear to be tissue-specific.
In intestinal and gastric epithelial cells, a fraction of LIN7 is colocalized with ZO-1 at the apical junctional complex. This pool of LIN7 is unaffected by the loss of CASK. A junctional localization of LIN7 is expected from its known association with the tight junction MAGUK, Pals1 Roh et al., 2002) . That LIN7 plays an important role in tight junction assembly has been demonstrated using small hairpin RNA-induced knockdown of its expression in MDCK cells (Straight et al., 2006) . Furthermore, LIN7C knockout mice display severe kidney defects resulting from tight junction abnormalities and disrupted polarity of a subset of renal epithelial cells (Olsen et al., 2007) . Although CASK-deficient intestinal epithelium shows displacement of LIN7C from basolateral membranes, the fact that its junctional pool of LIN7 remains intact probably explains the absence of the sort of overt polarity defects seen in LIN7C knockouts.
There is a good deal of evidence that LIN7 is involved in the basolateral targeting of certain transmembrane proteins. A relatively small protein, LIN7 contains an L27 domain that mediates interaction with CASK (or Pals proteins, (Doerks et al., 2000) ) and a PDZ domain that mediates binding to a motif located at the C-terminus of some transmembrane proteins. Among the proteins with PDZ-binding C-terminal motifs recognized by LIN7 are: the epithelial -aminobutyric acid transporter, BGT-1 (Perego et al., 1999) ; -catenin (Perego et al., 2000) ;
inwardly-rectifying potassium channels of the Kir 2 family (Olsen et al., 2002; Leonoudakis et al., 2004) ; and two of the four mammalian ErbB receptors (Shelly et al., 2003) . Several studies have analyzed the effects of LIN7 on the membrane targeting of these proteins when expressed in MDCK cells. In the cases of BGT-1, Kir 2.3, Kir 2.2 and ErbB-2, removal of the C-terminal motif, which leads to de-coupling from LIN7, causes destabilization of the channel/receptor at the basolateral membrane and internalization into endosomes (Perego et al., 1999; Olsen et al., 2002; Shelly et al., 2003; Leonoudakis et al., 2004) . These and related observations have led to the model that LIN7 functions as an adaptor linking specific channel and receptor proteins to CASK, thereby stabilizing them in the basolateral plasma membrane by preventing their endocytosis (and possibly also by promoting their recycling to the plasma membrane from endosomes). In addition, LIN7 plays a role in regulating the trafficking of some proteins through the biosynthetic pathway: it is required for the translocation of newly synthesized ErbB-2 from the endoplasmic reticulum to the Golgi apparatus in MDCK cells (Shelly et al., 2003) . This PDZ-independent function is mediated by binding of LIN7 to the tyrosine kinase domain of ErbB-2 through a region designated the "kinase interaction domain" (KID). That EGFR trafficking may be similarly regulated is suggested by the fact that it, too binds the KID domain of LIN7. Furthermore, the KID sequence is highly conserved, and all three LIN7 isoforms are capable of binding to EGFR (Shelly et al., 2003) .
Our finding that EGFR and ErbB-2 are correctly localized at the basolateral plasma membranes of CASK-deficient intestinal crypt epithelial cells demonstrates that LIN7 does not require the cooperation of CASK to promote the trafficking of these receptors through the biosynthetic pathway. The loss of basolateral membrane anchoring of LIN7C implies that CASK specifically tethers this isoform to the membrane. However, the LIN7A and/or B isoforms remain at basolateral membranes in the absence of CASK. Thus, they are available for PDZmediated binding of ErbB-2 and are presumably responsible for its stabilization in the plasma membrane. EGFR, which lacks a C-terminal PDZ-binding motif, is maintained in the membrane by other mechanisms.
Fully mature, CASK-deficient epithelial cells of small intestinal villi show a complete absence of basolateral membrane-associated LIN7 when stained with an antibody that recognizes all three isoforms. The most likely explanation is that LIN7C is the only isoform expressed in villi, whereas one or both of the other isoforms is/are expressed in crypts. This situation is reminiscent of that in the kidney, where there is differential expression of the three LIN7
isoforms in different segments of the nephron (Olsen et al., 2005) . Neither EGFR nor ErbB-2 is detectable in the fully-differentiated villus epithelium, as expected for a non-proliferative cell population.
Syndecan is another basolateral receptor that is expressed by intestinal epithelia and associates with CASK (Cohen et al., 1998) . Like ErbB-2, syndecan has a PDZ binding motif at its cytoplasmic C-terminus. Syndecan's motif, however, does not bind LIN7 but rather binds directly to the PDZ domain of CASK. Although there is strong evidence that in MDCK cells a PDZ interaction controls the biosynthetic sorting of syndecan and thereby determines its basolateral localization, siRNA experiments have shown that this process is independent of CASK (Maday et al., 2008) . Accordingly, we find that the loss of CASK in intestinal epithelia has no effect on the localization of syndecan.
MPP7, a recently characterized MAGUK, is structurally similar to CASK and is expressed in a variety of epithelial cell lines. Like CASK, it can interact with LIN7 and DLG1, and in vitro it competes with CASK for binding to those proteins (Bohl et al., 2007; Stucke et al., 2007) . However, MPP7 does not play the same role as CASK in anchoring DLG1 to the basolateral membrane. In fact, siRNA knockdown experiments in a polarized breast epithelial cell line have shown that although DLG1 remains basolateral in the absence of MPP7, MPP7
loses its basolateral membrane distribution in the absence of DLG1 (Stucke et al., 2007) .
Interestingly, siRNA knockdown of CASK in these cells has no effect on DLG1 localization (Stucke et al., 2007) , which may be further evidence of the tissue specificity of CASK's function.
Although the precise biochemical action(s) of DLG1 are poorly understood, its membrane localization appears to be critical for its effects on cell polarity, migration and proliferation. In Drosophila, Dlg is necessary for the formation of new plasma membranes during cellularization of syncitial embryos (Lee et al., 2003) , and for the establishment of apicobasal polarity in developing epithelia (Bilder et al., 2003) . In cultured mammalian epithelial cells, DLG1's membrane recruitment is promoted by cell-cell contact (Reuver and Garner, 1998) and its abundance is regulated through the proteasome pathway (Mantovani et al., 2001) . The transforming capacity of several viral oncoproteins depends on their ability to bind DLG1 and target it for degradation (Lee et al., 1997; Grassmann et al., 2005; Thomas et al., 2005) . In migrating cells, DLG1 is associated with the basal plasma membrane and concentrates in the leading edge, at the attachment points of microtubule plus ends (Etienne-Manneville et al., 2005; Mimori-Kiyosue et al., 2007) . At these sites, DLG1 and APC form a complex that is essential for directed cell migration. The DLG1-APC interaction is also reported to inhibit cell cycle progression in fibroblasts, but the subcellular site(s) at which this occurs and its molecular mechanism are unknown (Ishidate et al., 2000) . Interestingly, overexpression of truncated APCwhich cannot bind DLG1 and is similar in this respect to mutant forms typically expressed by colon cancer cells -causes a loss of contact inhibition in epithelia (Mimori-Kiyosue et al., 2007) .
Together, these observations strongly implicate DLG1 in polarity and proliferation control and indicate that many of its functions depend on its association with the plasma membrane.
However, the results presented here demonstrate that de-coupling of DLG1 from the basolateral membranes of intestinal epithelial cells in vivo has no apparent effect on their polarity, self-renewal, differentiation or crypt-to-villus migration. In future studies, it will be interesting to examine the proliferative and migratory responses of such CASK-deficient cells in mouse models of intestinal mucosal injury and repair, as well as the effects of CASK gene deletion on intestinal carcinogenesis. (E) and II-spectrin (F). The absence of CASK has no effect on the distribution patterns of these proteins. Identical pairs of samples were separated by gel electrophoresis and blotted to nitrocellulose.
Blots were probed with antibodies to the indicated proteins. (E-cad = E-cadherin) 
